Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoid vs Glucocorticoid + MMF in High-Risk Type I Autoimmune Pancreatitis (AIP)
NCT06468709Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jun 2024
- Primary completion
- Sep 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil in Autoimmune pancreatitis type I (AIP), sponsored by Ruijin Hospital. Started Jun 2024; status: recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
Autoimmune pancreatitis type I (AIP)
Beyond the preview
Go deeper on NCT06468709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06468709.